Intra-Cellular Therapies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 16, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1	38	20	61	-
Market Cap Growth	91.33%	91.33%	-67.69%	-	-
Enterprise Value	18	37	30	90	-
Last Close Price	0.03	1.14	7.60	9.99	-
PS Ratio	0.12	4.18	1.61	5.81	-
PB Ratio	-0.04	-1.24	-1.13	-6.08	-
EV/Sales Ratio	2.01	4.11	2.48	8.62	-
Debt / Equity Ratio	-0.66	-0.66	-0.64	-0.65	-0.92
Asset Turnover	1.47	1.47	2.20	2.62	-
Inventory Turnover	7.48	7.48	9.00	13.23	-
Quick Ratio	0.20	0.20	0.36	0.31	0.05
Current Ratio	0.30	0.30	1.26	0.71	0.10
Return on Assets (ROA)	-260.10%	-260.10%	-139.91%	-513.26%	-
Earnings Yield	-2605.38%	-76.76%	-63.55%	-52.50%	-
FCF Yield	-898.01%	-26.46%	-26.52%	-9.30%	-
Buyback Yield / Dilution	-10.02%	-10.02%	-	75.50%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.